Medical Research Council Laboratories, Fajara, The Gambia.
PLoS One. 2012;7(2):e31142. doi: 10.1371/journal.pone.0031142. Epub 2012 Feb 8.
Burkitt's lymphoma (BL), an EBV-associated tumour, occurs at high incidence in populations where malaria is holoendemic. Previous studies in one such population suggested that acute P.falciparum infection impairs EBV-specific T-cell surveillance, allowing expansion of EBV infected B-cells from which BL derives. We re-examined the situation in the same area, The Gambia, after a reduction in malaria endemicity. Cellular immune responses to EBV were measured in children with uncomplicated malaria before (day 0) and after treatment (day 28), comparing EBV genome loads in blood and EBV-specific CD8(+) T-cell numbers (assayed by MHC Class I tetramers and IFNγ ELISPOTS) with those seen in age- and sex-matched healthy controls. No significant changes were seen in EBV genome loads, percentage of EBV-specific CD8(+) T-cells and IFNγ producing T-cells in acute versus convalescent samples, nor any difference versus controls. Regression assays performed also no longer detected any impairment of EBV-specific T-cell surveillance. Acute uncomplicated malaria infection no longer alters EBV-specific immune responses in children in The Gambia. Given the recent decline in malaria incidence in that country, we hypothesise that gross disturbance of the EBV-host balance may be a specific effect of acute malaria only in children with a history of chronic/recurrent malaria challenge.
伯基特淋巴瘤(BL)是一种 EBV 相关肿瘤,在疟疾高度流行的人群中发病率较高。之前在一个这样的人群中的研究表明,急性疟原虫感染会损害 EBV 特异性 T 细胞监测,从而允许 EBV 感染的 B 细胞扩增,BL 就是由此产生的。在疟疾流行率降低后,我们在同一地区冈比亚重新检查了这种情况。在治疗前(第 0 天)和治疗后(第 28 天),对患有无并发症疟疾的儿童进行 EBV 细胞免疫反应测量,比较血液中的 EBV 基因组载量和 EBV 特异性 CD8(+)T 细胞数量(通过 MHC 类 I 四聚体和 IFNγ ELISPOTS 测定)与年龄和性别匹配的健康对照组。在急性与恢复期样本中,未观察到 EBV 基因组载量、EBV 特异性 CD8(+)T 细胞和 IFNγ 产生 T 细胞的百分比有任何变化,与对照组也没有差异。回归分析也没有检测到 EBV 特异性 T 细胞监测的任何损害。急性无并发症疟疾感染不再改变冈比亚儿童的 EBV 特异性免疫反应。鉴于该国疟疾发病率最近下降,我们假设 EBV-宿主平衡的严重紊乱可能只是在有慢性/复发性疟疾挑战史的儿童中,急性疟疾的特定影响。